Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Frontiers in Cell and Developmental Biology|January 28, 2026
The fall of the genome protectors triad: PBRM1, SETD2, and BAP1's impact on metabolism and immunity in clear cell renal cell carcinomaMathieu Johnson, Sandra Turcotte
Current Opinion in Cell Biology|January 9, 2010
Targeting cancer cells through autophagy for anticancer therapySandra Turcotte, Amato J Giaccia
Advances in Experimental Medicine and Biology|November 26, 2013
Autophagy and cell death to target cancer cells: exploiting synthetic lethality as cancer therapiesJulie Reyjal, Kevin Cormier, Sandra Turcotte
Frontiers in Cell and Developmental Biology|January 3, 2022
A Compendium of Information on the LysosomeNadia Bouhamdani, Dominique Comeau, Sandra Turcotte
Journal of Cell Science|April 17, 2003
HIF-1alpha mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinomaSandra Turcotte, Richard R Desrosiers, Richard Béliveau
American Journal of Physiology. Renal Physiology|October 30, 2003
Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinomaSandra Turcotte, Richard R Desrosiers, Richard Beliveau
American Journal of Physiology. Cell Physiology|February 14, 2019
STF-62247 accumulates in lysosomes and blocks late stages of autophagy to selectively target von Hippel-Lindau-inactivated cellsNadia Bouhamdani, Dominique Comeau, Kevin Cormier, et al.
International Journal of Cancer|September 24, 2004
von Hippel-Lindau tumor suppressor protein stimulation by thrombin involves RhoA activationSandra Turcotte, Richard R Desrosiers, Geneviève Brand, et al.
Pageof 3